首页 | 本学科首页   官方微博 | 高级检索  
     

吉非替尼初治有效的非小细胞肺癌进展后吉非替尼再治疗的疗效评估
引用本文:赵明芳,何燕燕. 吉非替尼初治有效的非小细胞肺癌进展后吉非替尼再治疗的疗效评估[J]. 循证医学, 2013, 13(1): 43-45. DOI: 10.3969/j.issn.1671-5144.2013.01.007
作者姓名:赵明芳  何燕燕
作者单位:1. 中国医科大学附属第一医院肿瘤内科, 沈阳110001; 2. 广东省人民医院肿瘤中心、广东省医学科学院、广东省肺癌研究所, 广州510080
摘    要:
1文献来源 Oh I J, Ban H J, Kim KS,et al. Retreatment of Gefitinib in patients with non-small-cell lung cancerwho previously controlled arm, open-label, phase Ⅱ 2012, 77(1): 121-127. to Gefitinib: A single- study[J]. Lung Cancer.2 证据水平

关 键 词:非小细胞肺癌  吉非替尼  再治疗

Assessment of Retreatment of Gefitinib in Patients with Non-Small-Cell Lung Cancer Who Previously Controlled to Gefitinib
ZHAO Ming-fang , HE Yan-yan. Assessment of Retreatment of Gefitinib in Patients with Non-Small-Cell Lung Cancer Who Previously Controlled to Gefitinib[J]. The Journal of Evidence-Based Medicine, 2013, 13(1): 43-45. DOI: 10.3969/j.issn.1671-5144.2013.01.007
Authors:ZHAO Ming-fang    HE Yan-yan
Affiliation:Medical Oncology, The First Affiliated Hospital, China Medical University, Shenyang 110001, China
Abstract:
non-small-cell lung cancer Gefitinib retreatment
Keywords:non-small-cell lung cancer  Gefitinib  retreatment
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《循证医学》浏览原始摘要信息
点击此处可从《循证医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号